NewAmsterdam Pharma Company N.V.NAMSNASDAQ
Loading
Operating Income ContractionContracting
Percentile Rank0
Studio
Year-over-Year Change

Profit from core business operations before interest and taxes

Latest
$-225.68M
↓ 115% vs avg
Percentile
P0
Near historical low
Streak
1 yr
Consecutive declineContracting
Average
$-105.02M
Historical baseline
PeriodValueYoY Change
2025$-225.68M-28.0%
2024$-176.29M+3.6%
2023$-182.97M-5043.9%
2022$-3.56M+89.8%
2021$-34.98M-427.4%
2020$-6.63M-